The Zhitong Finance App learned that Citi released a research report saying that the US Department of Defense recently decided to remove Yao Ming Kangde (02359.HK) from the 1260H list to comply with the US District Court's order; the bank believes that this move is significantly positive for Yao Ming Kangde's stock price and the overall sentiment of the CXO sub-sector in the mainland, with a target price of HK$240 and a “buy” rating, and included in the positive catalyst watch list. The bank pointed out that the removal of Medicinal Kangde from the list also means that the company can now participate in US federally funded projects.

Zhitongcaijing · 6d ago
The Zhitong Finance App learned that Citi released a research report saying that the US Department of Defense recently decided to remove Yao Ming Kangde (02359.HK) from the 1260H list to comply with the US District Court's order; the bank believes that this move is significantly positive for Yao Ming Kangde's stock price and the overall sentiment of the CXO sub-sector in the mainland, with a target price of HK$240 and a “buy” rating, and included in the positive catalyst watch list. The bank pointed out that the removal of Medicinal Kangde from the list also means that the company can now participate in US federally funded projects.